Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022
Fiona P. Havers
,
Kadam Patel
,
Michael Whitaker
,
Jennifer Milucky
,
Arthur Reingold
,
Isaac Armistead
,
James I. Meek
,
Andrew Weigel
,
Libby Reeg
,
Scott Seys
,
Susan L. Ropp
,
Nancy Spina
,
Christina B. Felsen
,
Nancy E. Moran
,
Melissa Sutton
,
H Keipp Talbot
,
Andrea George
,
Christopher A. Taylor
,
Pam Daily Kirley
,
Nisha B Alden
,
Kimberly Yousey-Hindes
,
Kyle P. Openo
,
Chloe Brown
,
Cody T. Schardin
,
Kelly Plymesser
,
Grant Barney
,
Kevin Popham
,
Laurie M. Billing
,
Nasreen Abdullah
,
Tiffanie M. Markus
,
Mary Hill
Publication type: Journal Article
Publication date: 2022-08-26
scimago Q1
wos Q1
SJR: 9.559
CiteScore: 39.4
Impact factor: 17.3
ISSN: 01492195, 1545861X
PubMed ID:
36006841
General Medicine
Health, Toxicology and Mutagenesis
Epidemiology
Health (social science)
Health Information Management
Abstract
Beginning the week of March 20–26, 2022, the Omicron BA.2 variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating variant in the United States, accounting for >50% of sequenced isolates.* Data from the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to describe recent COVID-19–associated hospitalization rates among adults aged ≥18 years during the period coinciding with BA.2 predominance (BA.2 period [Omicron BA.2 and BA.2.12.1; March 20–May 31, 2022]). Weekly hospitalization rates (hospitalizations per 100,000 population) among adults aged ≥65 years increased threefold, from 6.9 (week ending April 2, 2022) to 27.6 (week ending May 28, 2022); hospitalization rates in adults aged 18–49 and 50–64 years both increased 1.7-fold during the same time interval. Hospitalization rates among unvaccinated adults were 3.4 times as high as those among vaccinated adults. Among hospitalized nonpregnant patients in this same period, 39.1% had received a primary vaccination series and 1 booster or additional dose; 5.0% had received a primary series and ≥2 boosters or additional doses. All adults should stay up to date† with COVID-19 vaccination, and multiple nonpharmaceutical and medical prevention measures should be used to protect those at high risk for severe COVID-19 illness, irrespective of vaccination status§ (1).Beginning the week of March 20–26, 2022, the Omicron BA.2 variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating variant in the United States, accounting for >50% of sequenced isolates.* Data from the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to describe recent COVID-19–associated hospitalization rates among adults aged ≥18 years during the period coinciding with BA.2 predominance (BA.2 period [Omicron BA.2 and BA.2.12.1; March 20–May 31, 2022]). Weekly hospitalization rates (hospitalizations per 100,000 population) among adults aged ≥65 years increased threefold, from 6.9 (week ending April 2, 2022) to 27.6 (week ending May 28, 2022); hospitalization rates in adults aged 18–49 and 50–64 years both increased 1.7-fold during the same time interval. Hospitalization rates among unvaccinated adults were 3.4 times as high as those among vaccinated adults. Among hospitalized nonpregnant patients in this same period, 39.1% had received a primary vaccination series and 1 booster or additional dose; 5.0% had received a primary series and ≥2 boosters or additional doses. All adults should stay up to date† with COVID-19 vaccination, and multiple nonpharmaceutical and medical prevention measures should be used to protect those at high risk for severe COVID-19 illness, irrespective of vaccination status§ (1).
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Viruses
2 publications, 7.14%
|
|
|
The Lancet Respiratory Medicine
1 publication, 3.57%
|
|
|
European Respiratory Journal
1 publication, 3.57%
|
|
|
Morbidity and Mortality Weekly Report
1 publication, 3.57%
|
|
|
Journal of the Pediatric Infectious Diseases Society
1 publication, 3.57%
|
|
|
JAMA Internal Medicine
1 publication, 3.57%
|
|
|
Scientific Reports
1 publication, 3.57%
|
|
|
Healthcare
1 publication, 3.57%
|
|
|
Journal of Experimental Medicine
1 publication, 3.57%
|
|
|
Leukemia and Lymphoma
1 publication, 3.57%
|
|
|
Frontiers in Immunology
1 publication, 3.57%
|
|
|
JMIR Medical Informatics
1 publication, 3.57%
|
|
|
AIDS and Behavior
1 publication, 3.57%
|
|
|
Vaccine
1 publication, 3.57%
|
|
|
Journal of the American Medical Directors Association
1 publication, 3.57%
|
|
|
Auris Nasus Larynx
1 publication, 3.57%
|
|
|
Human Vaccines and Immunotherapeutics
1 publication, 3.57%
|
|
|
Journal of Infectious Diseases
1 publication, 3.57%
|
|
|
Vaccines
1 publication, 3.57%
|
|
|
Open Forum Infectious Diseases
1 publication, 3.57%
|
|
|
Antimicrobial Stewardship & Healthcare Epidemiology
1 publication, 3.57%
|
|
|
Virus Research
1 publication, 3.57%
|
|
|
Journal of racial and ethnic health disparities
1 publication, 3.57%
|
|
|
Annals of Epidemiology
1 publication, 3.57%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
|
|
|
Elsevier
6 publications, 21.43%
|
|
|
MDPI
4 publications, 14.29%
|
|
|
Oxford University Press
3 publications, 10.71%
|
|
|
Springer Nature
3 publications, 10.71%
|
|
|
Taylor & Francis
2 publications, 7.14%
|
|
|
JMIR Publications
2 publications, 7.14%
|
|
|
European Respiratory Society (ERS)
1 publication, 3.57%
|
|
|
Centers for Disease Control MMWR Office
1 publication, 3.57%
|
|
|
American Medical Association (AMA)
1 publication, 3.57%
|
|
|
Rockefeller University Press
1 publication, 3.57%
|
|
|
Frontiers Media S.A.
1 publication, 3.57%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 3.57%
|
|
|
IntechOpen
1 publication, 3.57%
|
|
|
Cambridge University Press
1 publication, 3.57%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
28
Total citations:
28
Citations from 2024:
10
(35.71%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Havers F. P. et al. Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022 // Morbidity and Mortality Weekly Report. 2022. Vol. 71. No. 34. pp. 1085-1091.
GOST all authors (up to 50)
Copy
Havers F. P., Patel K., Whitaker M., Milucky J., Reingold A., Armistead I., Meek J. I., Anderson E. M., Weigel A., Reeg L., Seys S., Ropp S. L., Spina N., Felsen C. B., Moran N. E., Sutton M., Talbot H. K., George A., Taylor C. A., Daily Kirley P., Alden N. B., Yousey-Hindes K., Openo K. P., Brown C., Schardin C. T., Plymesser K., Barney G., Popham K., Billing L. M., Abdullah N., Markus T. M., Hill M. Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022 // Morbidity and Mortality Weekly Report. 2022. Vol. 71. No. 34. pp. 1085-1091.
Cite this
RIS
Copy
TY - JOUR
DO - 10.15585/mmwr.mm7134a3
UR - http://www.cdc.gov/mmwr/volumes/71/wr/mm7134a3.htm?s_cid=mm7134a3_w
TI - Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022
T2 - Morbidity and Mortality Weekly Report
AU - Havers, Fiona P.
AU - Patel, Kadam
AU - Whitaker, Michael
AU - Milucky, Jennifer
AU - Reingold, Arthur
AU - Armistead, Isaac
AU - Meek, James I.
AU - Anderson, Evan M.
AU - Weigel, Andrew
AU - Reeg, Libby
AU - Seys, Scott
AU - Ropp, Susan L.
AU - Spina, Nancy
AU - Felsen, Christina B.
AU - Moran, Nancy E.
AU - Sutton, Melissa
AU - Talbot, H Keipp
AU - George, Andrea
AU - Taylor, Christopher A.
AU - Daily Kirley, Pam
AU - Alden, Nisha B
AU - Yousey-Hindes, Kimberly
AU - Openo, Kyle P.
AU - Brown, Chloe
AU - Schardin, Cody T.
AU - Plymesser, Kelly
AU - Barney, Grant
AU - Popham, Kevin
AU - Billing, Laurie M.
AU - Abdullah, Nasreen
AU - Markus, Tiffanie M.
AU - Hill, Mary
PY - 2022
DA - 2022/08/26
PB - Centers for Disease Control MMWR Office
SP - 1085-1091
IS - 34
VL - 71
PMID - 36006841
SN - 0149-2195
SN - 1545-861X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Havers,
author = {Fiona P. Havers and Kadam Patel and Michael Whitaker and Jennifer Milucky and Arthur Reingold and Isaac Armistead and James I. Meek and Evan M. Anderson and Andrew Weigel and Libby Reeg and Scott Seys and Susan L. Ropp and Nancy Spina and Christina B. Felsen and Nancy E. Moran and Melissa Sutton and H Keipp Talbot and Andrea George and Christopher A. Taylor and Pam Daily Kirley and Nisha B Alden and Kimberly Yousey-Hindes and Kyle P. Openo and Chloe Brown and Cody T. Schardin and Kelly Plymesser and Grant Barney and Kevin Popham and Laurie M. Billing and Nasreen Abdullah and Tiffanie M. Markus and Mary Hill},
title = {Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022},
journal = {Morbidity and Mortality Weekly Report},
year = {2022},
volume = {71},
publisher = {Centers for Disease Control MMWR Office},
month = {aug},
url = {http://www.cdc.gov/mmwr/volumes/71/wr/mm7134a3.htm?s_cid=mm7134a3_w},
number = {34},
pages = {1085--1091},
doi = {10.15585/mmwr.mm7134a3}
}
Cite this
MLA
Copy
Havers, Fiona P., et al. “Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022.” Morbidity and Mortality Weekly Report, vol. 71, no. 34, Aug. 2022, pp. 1085-1091. http://www.cdc.gov/mmwr/volumes/71/wr/mm7134a3.htm?s_cid=mm7134a3_w.
Profiles